Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice
Vanessa Hartwig(Heidelberg University), Steven Dooley(Heidelberg University), Christoph Ganss(Rheacell (Germany)), Matthias Ebert(University of Mannheim), Nils Tappenbeck(Rheacell (Germany)), Anne Dropmann(University Hospital Heidelberg), Roger Vogelmann(Newron Pharmaceuticals (Italy)), Mark A. Kluth(Leibniz Institute of Virology (LIV)), Lysann Tietze(Leipzig University), Markus H. Frank(Brigham and Women's Hospital), Tao Lin(Shanghai Academy of Agricultural Sciences), Bruno Christ(Fraunhofer Institute for Silicate Research), Bedair Dewidar(Tanta University)
Cited by 11
Related Papers
The therapeutic promise of the cancer stem cell concept
|Journal of Clinical Investigation|2010|639
<scp>TGF</scp>‐β signalling and liver disease
|FEBS Journal|2016|611
Hepatocyte-Specific Smad7 Expression Attenuates TGF-β–Mediated Fibrogenesis and Protects Against Liver Damage
|Gastroenterology|2008|272
Present status and perspectives of cell-based therapies for liver diseases
|Journal of Hepatology|2006|205